Match tier
Likely match
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-16
K
Kelly L. Harris
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Staff Fellow
Staff Researcher
11 h-index
45 pubs
952 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Kelly L. Harris is a Staff Fellow at the National Center for Toxicological Research. Her research focuses on the molecular mechanisms of carcinogenesis, particularly the effects of environmental agents on DNA and gene expression. Harris has investigated the impact of benzo(a)pyrene on human colon cancer cells, examining cytotoxicity, proliferation, and DNA damage.
Her work also includes the development and application of methods for measuring cancer driver mutations. This includes studies using the CarcSeq approach to assess mutations in rat mammary and mouse lung cancer models, correlating these findings with incidence rates and strain/sex-specific variations. Collaborations within the National Center for Toxicological Research include work with Barbara L. Parsons, Binsheng Gong, Jennifer Faske, and Meagan B. Myers, with whom she has co-authored multiple publications. Harris has an h-index of 11 and has published 45 papers, accumulating 952 citations.
Metrics
- h-index: 11
- Publications: 45
- Citations: 952
Selected Publications
-
Abstract C054: Pharmacogenomics evaluation of histone deacetylase inhibitors on the treatment of triple-negative breast cancer subtypes (2025)
-
Tissue and Sex‐Specific Performance of a Cancer Driver Based Biomarker in <scp>rasH2</scp> ‐Tg Mice (2025)
-
Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations (2024)
-
Abstract 2440: Cancer driver mutations as quantitative biomarkers of cancer risk interspecies analyses using CarcSeq (2024)
-
Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia (2021)
-
Quantification of cancer driver mutations in human breast and lung <scp>DNA</scp> using targeted, error‐corrected <scp>CarcSeq</scp> (2020)
-
Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk (2019)
Collaboration Network
Top Collaborators
Barbara L. Parsons
National Center for Toxicological Research
4 shared publications
In database
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
- Tissue and Sex‐Specific Performance of a Cancer Driver Based Biomarker in <scp>rasH2</scp> ‐Tg Mice
- Abstract 2440: Cancer driver mutations as quantitative biomarkers of cancer risk interspecies analyses using CarcSeq
Binsheng Gong
National Center for Toxicological Research
3 shared publications
In database
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
- Tissue and Sex‐Specific Performance of a Cancer Driver Based Biomarker in <scp>rasH2</scp> ‐Tg Mice
- Abstract 2440: Cancer driver mutations as quantitative biomarkers of cancer risk interspecies analyses using CarcSeq
Jennifer Faske
National Center for Toxicological Research
3 shared publications
In database
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
- Tissue and Sex‐Specific Performance of a Cancer Driver Based Biomarker in <scp>rasH2</scp> ‐Tg Mice
- Abstract 2440: Cancer driver mutations as quantitative biomarkers of cancer risk interspecies analyses using CarcSeq
Joshua Xu
National Center for Toxicological Research
2 shared publications
In database
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
- Abstract 2440: Cancer driver mutations as quantitative biomarkers of cancer risk interspecies analyses using CarcSeq
Karen L. McKim
National Center for Toxicological Research
1 shared publication
In database
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
Meagan B. Myers
United States Food and Drug Administration
1 shared publication
In database
- Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
Yiying Wang
National Center for Toxicological Research (US)
1 shared publication
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
Yuan Le
National Center for Toxicological Research
1 shared publication
In database
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
Ying Chen
United States Food and Drug Administration
1 shared publication
In database
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
Xilin Li
National Center for Toxicological Research
1 shared publication
In database
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
Rebecca Wynne
United States Food and Drug Administration
1 shared publication
In database
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
Roberta A. Mittelstaedt
National Center for Toxicological Research
1 shared publication
In database
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
Xuefei Cao
United States Food and Drug Administration
1 shared publication
In database
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
Jaime A. Miranda
United States Food and Drug Administration
1 shared publication
In database
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
Lana Elkins
National Center for Toxicological Research
1 shared publication
In database
- Repeat treatment of organotypic airway cultures with ethyl methanesulfonate causes accumulation of somatic cell mutations without expansion of bronchial-carcinoma-specific cancer driver mutations
Similar Researchers
Based on overlapping research topics
Meagan B. Myers
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Ji‐Eun Seo
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Jennifer Faske
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Igor P. Pogribny
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Joshua Z. Yu
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
S A Montoya Guerrero
National Center for Toxicological Research
Carcinogens and Genotoxicity Assessment
Pharmacological Effects and Toxicity Studies
Disease Models, Animal